Work

High Response Rate to Lenalidomide in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma with Prior Stem Cell Transplant.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.2570.2570

Authors: Julie M. Vose, Joseph M. Tuscano, Glen Justice, Izidore S. Lossos, Annette Ervin-Haynes, Kenichi Takeshita, Dennis Pietronigro, Jerome B. Zeldis, Thomas M. Habermann

Institutions: Nebraska Medical Center, University of Nebraska Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis, University of Miami, Sylvester Comprehensive Cancer Center, Celgene (United States), Mayo Clinic

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2573958419

FWCI: 0.233

Cites:

Cited by: 1

Related to: 10